Eagle Genomics

Eagle Genomics is a private, revenue-generating platform company founded in 2008 and headquartered in Cambridge, UK. It provides a sophisticated software platform that applies network science, hypergraph technology, and AI to unify and analyze complex multi-omics microbiome data. The company targets innovation-driven clients in the food & nutrition, beauty & personal care, AgBio, and biopharma sectors, helping them derive actionable insights, prioritize targets, and build evidence for product claims. Its business model is centered on providing its platform and applications as a service to enterprise partners.

e[datascientist]™ platform: A cloud-native microbiome knowledge discovery platform using network science, multi-layer hypergraph technology, AI, and causal analysis to unify and extract insights from complex multi-omics data.

Eagle Genomics competes in the life science informatics space, facing competition from generic cloud AI/ML services (AWS, Google), broad bioinformatics suites (Qiagen, DNAnexus), and specialized microbiome analysis tools. Its differentiation lies in its dedicated focus on the microbiome, its use of hypergraph network science (beyond standard stats), and its packaged applications for end-to-end innovation workflows in non-pharma industries.